Virtus ETF Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-753
| Closed | -$303K | – | 796 |
|
|
2024
Q4 | $303K | Sell |
753
-1,723
| -70% | -$799K | 0.12% | 244 |
|
|
2024
Q3 | $1.15M | Sell |
2,476
-310
| -11% | -$149K | 0.54% | 10 |
|
|
2024
Q2 | $1.31M | Buy |
2,786
+129
| +5% | +$56K | 0.64% | 4 |
|
|
2024
Q1 | $1.11M | Buy |
2,657
+264
| +11% | +$112K | 0.59% | 7 |
|
|
2023
Q4 | $974K | Sell |
2,393
-562
| -19% | -$208K | 0.62% | 1 |
|
|
2023
Q3 | $1.03M | Sell |
2,955
-400
| -12% | -$140K | 0.62% | 4 |
|
|
2023
Q2 | $1.18M | Sell |
3,355
-477
| -12% | -$161K | 0.7% | 2 |
|
|
2023
Q1 | $1.21M | Buy |
3,832
+291
| +8% | +$87.3K | 0.66% | 3 |
|
|
2022
Q4 | $1.02M | Buy |
3,541
+195
| +6% | +$59.4K | 0.53% | 6 |
|
|
2022
Q3 | $969K | Sell |
3,346
-260
| -7% | -$74.8K | 0.39% | 86 |
|
|
2022
Q2 | $1.02M | Buy |
3,606
+1,828
| +103% | +$489K | 0.38% | 86 |
|
|
2022
Q1 | $464K | Hold |
1,778
| – | – | 0.21% | 133 |
|
|
2021
Q4 | $390K | Sell |
1,778
-572
| -24% | -$111K | 0.15% | 159 |
|
|
2021
Q3 | $426K | Sell |
2,350
-213
| -8% | -$41.6K | 0.19% | 163 |
|
|
2021
Q2 | $517K | Sell |
2,563
-176
| -6% | -$36.8K | 0.21% | 138 |
|
|
2021
Q1 | $589K | Buy |
2,739
+71
| +3% | +$15.6K | 0.25% | 128 |
|
|
2020
Q4 | $631K | Buy |
2,668
+492
| +23% | +$113K | 0.26% | 99 |
|
|
2020
Q3 | $592K | Sell |
2,176
-3
| -0.1% | -$828 | 0.31% | 115 |
|
|
2020
Q2 | $633K | Sell |
2,179
-502
| -19% | -$136K | 0.3% | 102 |
|
|
2020
Q1 | $638K | Sell |
2,681
-227
| -8% | -$52.1K | 0.26% | 144 |
|
|
2019
Q4 | $637K | Sell |
2,908
-1,160
| -29% | -$235K | 0.1% | 173 |
|
|
2019
Q3 | $689K | Sell |
4,068
-688
| -14% | -$122K | 0.14% | 165 |
|
|
2019
Q2 | $872K | Buy |
4,756
+329
| +7% | +$57.5K | 0.18% | 162 |
|
|
2019
Q1 | $814K | Buy |
4,427
+892
| +25% | +$165K | 1.73% | 17 |
|
|
2018
Q4 | $586K | Sell |
3,535
-1,516
| -30% | -$263K | 0.1% | 51 |
|
|
2018
Q3 | $974K | Buy |
5,051
+340
| +7% | +$60.5K | 0.11% | 52 |
|
|
2018
Q2 | $801K | Sell |
4,711
-1,623
| -26% | -$252K | 0.71% | 25 |
|
|
2018
Q1 | $1.03M | Sell |
6,334
-484
| -7% | -$79.1K | 0.9% | 37 |
|
|
2017
Q4 | $1.02M | Sell |
6,818
-1,482
| -18% | -$219K | 1.28% | 14 |
|
|
2017
Q3 | $1.26M | Hold |
8,300
| – | – | 0.17% | 47 |
|
|
2017
Q2 | $1.07M | Sell |
8,300
-4,918
| -37% | -$592K | 0.16% | 57 |
|
|
2017
Q1 | $1.45M | Buy |
13,218
+1,271
| +11% | +$112K | 0.26% | 41 |
|
|
2016
Q4 | $880K | Buy |
11,947
+5,133
| +75% | +$418K | 0.26% | 75 |
|
|
2016
Q3 | $594K | Buy |
6,814
+859
| +14% | +$81.2K | 0.29% | 62 |
|
|
2016
Q2 | $512K | Buy |
5,955
+922
| +18% | +$79.7K | 0.38% | 57 |
|
|
2016
Q1 | $400K | Buy |
+5,033
| New | +$455K | 0.55% | 50 |
|
Other funds holding VRTX
